» Articles » PMID: 32290794

Mitochondrial Complex II and Reactive Oxygen Species in Disease and Therapy

Overview
Journal Redox Rep
Date 2020 Apr 16
PMID 32290794
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological conditions, i.e. cancer and neurodegenerative diseases. While the basic framework of CII involvement in ROS production has been defined, the fine details still await clarification. It is important to resolve these aspects to fully understand the role of CII in pathology and to explore its therapeutic potential in cancer and other diseases.

Citing Articles

The flexible chain: regulation of structure and activity of ETC complexes defines rate of ATP synthesis and sites of superoxide generation.

Bochkova Z, Baizhumanov A, Yusipovich A, Morozova K, Nikelshparg E, Fedotova A Biophys Rev. 2025; 17(1):55-88.

PMID: 40060020 PMC: 11885220. DOI: 10.1007/s12551-025-01270-5.


The alternative oxidase reconfigures the larval mitochondrial electron transport system to accelerate growth and development in .

Garcia G, Othonicar M, Campos A, Kilbourn E, Bicego K, Lerchner J bioRxiv. 2025; .

PMID: 40027816 PMC: 11870600. DOI: 10.1101/2025.02.20.639223.


Ferroptosis: iron release mechanisms in the bioenergetic process.

Lee J, Roh J Cancer Metastasis Rev. 2025; 44(1):36.

PMID: 40000477 DOI: 10.1007/s10555-025-10252-8.


Dysfunctional BCAA degradation triggers neuronal damage through disrupted AMPK-mitochondrial axis due to enhanced PP2Ac interaction.

Wu S, Chen Y, Su S, Fang P, Liu R, Tsai H Commun Biol. 2025; 8(1):105.

PMID: 39838082 PMC: 11751115. DOI: 10.1038/s42003-025-07457-6.


Facts, Dogmas, and Unknowns About Mitochondrial Reactive Oxygen Species in Cancer.

Junco M, Ventura C, Santiago Valtierra F, Maldonado E Antioxidants (Basel). 2025; 13(12.

PMID: 39765891 PMC: 11673973. DOI: 10.3390/antiox13121563.


References
1.
Iverson T, Maklashina E, Cecchini G . Structural basis for malfunction in complex II. J Biol Chem. 2012; 287(42):35430-35438. PMC: 3471735. DOI: 10.1074/jbc.R112.408419. View

2.
Maher M, Herath A, Udagedara S, Dougan D, Truscott K . Crystal structure of bacterial succinate:quinone oxidoreductase flavoprotein SdhA in complex with its assembly factor SdhE. Proc Natl Acad Sci U S A. 2018; 115(12):2982-2987. PMC: 5866609. DOI: 10.1073/pnas.1800195115. View

3.
Cecchini G . Function and structure of complex II of the respiratory chain. Annu Rev Biochem. 2003; 72:77-109. DOI: 10.1146/annurev.biochem.72.121801.161700. View

4.
Guo J, Lemire B . The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide. J Biol Chem. 2003; 278(48):47629-35. DOI: 10.1074/jbc.M306312200. View

5.
Kruspig B, Valter K, Skender B, Zhivotovsky B, Gogvadze V . Targeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy. Biochim Biophys Acta. 2016; 1863(8):2065-71. DOI: 10.1016/j.bbamcr.2016.04.026. View